Stocks
FibroGen (FGEN) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 6 333% | 1 282% | 1 282% | 766.1% | 11 229% | 18 957% | |||
| Changes by years, y/y, % | +2 701pp | -5 050pp | 0pp | -516pp | +10 463pp | +30.7% | |||
FibroGen. R&D/CAPEX, %
FibroGen. R&D/CAPEX, changes, pp
FibroGen (FGEN) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| R&D/CAPEX, % | 9 615% | 8 946% | 20 599% | 132 386% | 243 614% | 18 957% | ||
| Changes by years, y/y, % | +1 774pp | +255pp | +2 092pp | +119 783pp | +233 999pp | |||
| Changes by quarters, q/q, % | -2 988pp | -669pp | +11 652pp | +111 787pp | +111 228pp | |||
